Provided by Tiger Trade Technology Pte. Ltd.

Precigen

7.20
-0.2400-3.23%
Post-market: 7.18-0.0200-0.28%19:30 EDT
Volume:4.41M
Turnover:31.74M
Market Cap:2.57B
PE:-6.73
High:7.50
Open:7.50
Low:7.10
Close:7.44
52wk High:7.50
52wk Low:2.99
Shares:356.51M
Float Shares:194.00M
Volume Ratio:0.64
T/O Rate:2.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0700
EPS(LYR):-1.3727
ROE:-837.08%
ROA:-18.14%
PB:58.91
PE(LYR):-5.24

Loading ...

Precigen CEO Helen Sabzevari Disposes of 346,836 Common Shares Worth $2,042,858.04

Reuters
·
Jul 02

Precigen Shareholders Approve 7 Million-share Increase to 2023 Incentive Plan at Annual Meeting

Reuters
·
Jun 25

Clearfield And 2 Insider Picks For Strong Growth

Simply Wall St.
·
Jun 24

Precigen (PGEN) Stock Could Be 79% Undervalued After FDA Exclusivity Win

Simply Wall St.
·
Jun 21

Sector Update: Health Care

MT Newswires Live
·
Jun 15

Precigen Wins FDA Orphan Drug Exclusivity for Airway Disease Treatment

MT Newswires Live
·
Jun 15

Precigen reports PAPZIMEOS trial data show 83% complete responses sustained at least 36 months in RRP

Reuters
·
Jun 15

Precigen presents long-term follow-up data from study of Papzimeos

TIPRANKS
·
Jun 01

Precigen says PAPZIMEOS trial shows 83% of complete responders remain disease-free at 36 months+

Reuters
·
May 31

Precigen Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 28

Precigen, Inc. : H.c. Wainwright Raises Target Price to $14 From $11

THOMSON REUTERS
·
May 28

Precigen receives orphan drug exclusivity for papzimeos in the U.S.

TIPRANKS
·
May 27

Precigen Receives Orphan Drug Exclusivity for Papzimeos (Zopapogene Imadenovec-Drba) in the United States

THOMSON REUTERS
·
May 27

Precigen to join J.P. Morgan virtual investor fireside chat

Reuters
·
May 26

What Precigen (PGEN)'s PAPZIMEOS-Fueled Q1 Revenue Surge Means For Shareholders

Simply Wall St.
·
May 25

Precigen’s PAPZIMEOS Launch Drives Surging Q1 Revenue

TIPRANKS
·
May 20

Precigen Earnings Call Highlights PAPZIMEOS Launch Surge

TIPRANKS
·
May 15

Precigen Stock Climbs After Strong 1Q for Papzimeos Sales

Dow Jones
·
May 15

Precigen Shares up 7.2% After Q1 Revenue Beat

THOMSON REUTERS
·
May 14

BUZZ-U.S. STOCKS ON THE MOVE-Klarna, Biogen, Legence

Reuters
·
May 14